Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma.
Recent evidence indicates a crucial role of the immunoinhibitory receptor programmed death-1 (PD-1) in enforcing T-cell dysfunction during chronic viral infection and cancer. We assessed the impact of circulating soluble PD-1 (sPD-1) levels on long-term dynamics of hepatitis B virus (HBV) load and h...
Main Authors: | Hsiang-Yun Cheng, Pei-Jen Kang, Ya-Hui Chuang, Ya-Hui Wang, Meng-Chin Jan, Chih-Feng Wu, Chih-Lin Lin, Chun-Jen Liu, Yun-Fan Liaw, Shi-Ming Lin, Pei-Jer Chen, Shou-Dong Lee, Ming-Whei Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4245192?pdf=render |
Similar Items
-
Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors
by: Ming-Whei Yu, et al.
Published: (2022-08-01) -
Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B
by: Ming-Whei Yu, et al.
Published: (2022-12-01) -
Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results
by: Albert Qin, et al.
Published: (2023-12-01) -
Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology
by: Yi-Hao Yen, et al.
Published: (2023-03-01) -
TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma
by: Yang-Hsiang Lin, et al.
Published: (2020-01-01)